A case of sepsis in a pediatric patient due to the newly described Citrobacter species C. farmeri is described. Factors predisposing this child to infection included short-bowel syndrome requiring total parenteral nutrition.
Okla.). Gentamicin was added to his therapeutic regimen based upon the Gram stain result. Within 24 h, his condition had improved and his fever had decreased. Four days after admission, vancomycin and ceftazidime were discontinued and the patient was placed on 2 g of ceftriaxone (four times daily) and 100 mg of gentamicin (twice daily) based upon the susceptibility report for the blood isolate. The infection resolved without further sequelae and without the removal of the line. The TPN solution was not cultured.
Blood isolates were initially identified as Pantoea ("Enterobacter") agglomerans (very good identification) by the API 20E system (bioMérieux Vitek, Inc., Hazelwood, Mo.). As part of a research protocol the blood isolate was additionally tested by two other systems. The Vitek system (software version R03.01; bioMérieux Vitek, Inc.) identified this isolate as Enterobacter cloacae (72%, low probability). The MicroScan W/A system (Dade MicroScan Inc., West Sacramento, Calif.) identified this strain as Leclercia adecarboxylata (56%, low probability). None of these systems currently have updated databases including the new Citrobacter species. Because of these discrepancies, the strain was forwarded to the Microbial Diseases Laboratory for further evaluation. The strain (96A-03859) was an oxidasenegative, catalase-positive, gram-negative, facultatively anaerobic bacillus. On triple sugar iron, 96A-03859 produced an acid/acid with gas reaction (H 2 S negative) and was indole, urease, citrate, and KCN positive and lysine decarboxylase and Voges-Proskauer negative. These reactions placed this strain in the genus Citrobacter. Failure to produce acid from adonitol or D-arabitol and to utilize malonate as a source of energy indicated that it belonged in the C. amalonaticus group. Subsequent testing identified the strain as C. farmeri ("C. amalonaticus" biogroup 1) based upon the fermentation of key carbohydrates (Table 1) .
In 1985, Farmer and colleagues (3) described new groups within the family Enterobacteriaceae and defined a new biogroup of C. amalonaticus (biogroup) 1 based upon the ability of these strains to ferment sucrose, raffinose, ␣-methyl-D-glucoside, and melibiose and not utilize citrate. C. amalonaticus biogroup 1 ("C. farmeri") was described as a rarely isolated enteric bacterium from feces, urine, and wounds in that study. It was listed as possibly clinically significant at some sites but not at others. Further information was not available. In the subsequent systematic investigation of Brenner et al. (2) , the clinical distribution of C. farmeri was expanded to include blood although no clinical information on these strains was provided. Most C. farmeri strains are citrate negative (93%) at 48 h; however, 86% are reported to be citrate positive (Simmons) at 7 days (2).
In the present case report we provide the first clinical evidence indicating that C. farmeri is indeed a human pathogen. The fact that C. farmeri was isolated in pure culture twice from the blood of a child with systemic signs of sepsis (fever and chills) supports its role in the illness. The most likely factor triggering C. farmeri septicemia was the SBS condition causing TPN dependency. SBS is a serious medical complication resulting from major resection of the small intestine and in some instances the colon (9) . The remaining abbreviated intestine results in a malabsorption and malnutrition condition requiring TPN (5, 9) . A consequence of this required catheterization is sepsis, often involving gram-negative bacilli such as Escherichia coli, Klebsiella species, and Enterobacter cloacae (5, 7, 10) . Sepsis may result from the gastrointestinal translocation of gram-negative and gram-positive bacteria into the mesenteric lymph nodes, where they eventually spread hematogenously, seeding central venous catheters (5) . Alternatively, infection may result from the frequent bowel movements that SBS patients have, thereby increasing the chance of rectal contamination of central venous catheters (7) . In the present case, the short time span (13 min) that elapsed between the commencement of TPN and signs of sepsis suggests that the infection may have resulted from contaminated parenteral nutrition. Regardless of which mechanisms are operative, SBS patients run a much higher risk of developing sepsis, and C. farmeri should now be added to the list of agents documented to cause such infections. a Abbreviations: ϩ, Ն85% of strains positive for acid production from the indicated substrate (48 h); Ϫ, Յ15% of strains positive for acid production from the indicated substrates (48 h). Reactions for C. amalonaticus and C. farmeri are from the work of Farmer et al. (3) .
